FeesSafety
Pluang+

Genmab grants nearly 5,000 restricted stock units and 4,600 warrants to employees as part of compensation.

Company Fundamentals
18 Nov 2026, 21:40 WIB
GlobeNewsWire
View Source
Neutral
Genmab grants nearly 5,000 restricted stock units and 4,600 warrants to employees as part of compensation.

Genmab A/S announced the grant of 4,993 restricted stock units (RSUs) and 4,607 warrants to its employees and subsidiaries. Each RSU represents a conditional right to one share, vesting after three years, while warrants allow employees to buy shares at a set price after three years, expiring after seven years. This move aligns employee incentives with company performance and supports retention. Genmab is a biotechnology firm focused on innovative antibody medicines for cancer and serious diseases.

Genmab's grant of restricted stock units and warrants to employees provides context for the health sector's activity on Pluang. For readers following Health-sector US stocks, here is Pluang's market snapshot as of Nov 19, 2026 02:21 WIB: out of 150 priced stocks, 71 rose and 78 fell. Notable movers include UNH at USD 347.35 with a 1-day change of -10.86% and Pluang order activity of 88% Sell / 12% Buy, FLNA at USD 0.53 up 10.21% with 100% Sell orders, and WGS at USD 51.65 up 9.21% with 99% Sell orders.

More News

Bristol-Myers Squibb raises 2026 earnings forecast as new drug sales grow 12%

Bristol-Myers Squibb raises 2026 earnings forecast as new drug sales grow 12%

Bristol-Myers Squibb increased its full-year 2026 earnings guidance following a 12% revenue growth in its growth portfolio to $7.7 billion, driven by eight medicines each generating over $1 billion annually. The company is offsetting losses from pate...

Company Fundamentals
Bullish
55 minutes ago
Restaurant Brands posts strong Q3 sales growth, international expansion, and improved debt ratings.

Restaurant Brands posts strong Q3 sales growth, international expansion, and improved debt ratings.

Restaurant Brands reported 6.2% systemwide sales growth and 6.7% organic operating income growth in Q3 2026, driven by Burger King's U.S. same-store sales rising 8.4% and Popeyes expanding to over 2,000 international locations with $2 billion in sale...

Company Fundamentals
Bullish
55 minutes ago
Silgan plans to split into two companies after acquiring Trivium, raising full-year EPS forecast.

Silgan plans to split into two companies after acquiring Trivium, raising full-year EPS forecast.

Silgan announced it will acquire Trivium and separate into two independent packaging companies: Silgan Dispensing Solutions, focusing on high-growth dispensing products, and Silgan Metal Container Corporation, specializing in food packaging. Despite ...

Company Fundamentals
Bullish
55 minutes ago
Gladstone Capital's net investment income rises to $11M in Q4 2026, driven by equity gains and variable rate loans.

Gladstone Capital's net investment income rises to $11M in Q4 2026, driven by equity gains and variable rate loans.

Gladstone Capital reported net investment income of $11 million for Q4 fiscal 2026, supported by a focus on lower middle market lending and disciplined credit terms. The company’s equity investments generated $64.2 million in gains over five years, o...

Company Fundamentals
Bullish
1 hour ago
Voyage revenues soar 249% in Q3 2026 as C3is expands fleet and boosts earnings.

Voyage revenues soar 249% in Q3 2026 as C3is expands fleet and boosts earnings.

C3is reported a 249% increase in voyage revenues to $16.7 million for Q3 2026, driven by higher charter rates and a larger fleet including two new product tankers. The company achieved a 1,300% rise in adjusted net income for the first nine months, r...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App